MX9801920A - Composicion farmaceutica util para la transfeccion de acidos nucleicos y sus usos. - Google Patents
Composicion farmaceutica util para la transfeccion de acidos nucleicos y sus usos.Info
- Publication number
- MX9801920A MX9801920A MX9801920A MX9801920A MX9801920A MX 9801920 A MX9801920 A MX 9801920A MX 9801920 A MX9801920 A MX 9801920A MX 9801920 A MX9801920 A MX 9801920A MX 9801920 A MX9801920 A MX 9801920A
- Authority
- MX
- Mexico
- Prior art keywords
- nucleic acid
- pharmaceutical composition
- composition useful
- acid transfection
- transfection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invencion se refiere a una composicion farmacéutica util para la transfeccion de un ácido nucleico caracterizada porque contiene además de dicho ácido nucleico y al menos un agente de transfeccion, al menos un compuesto que asocia las propiedades de fijacion del ADN a una capacidad de vectorizacion nuclear de este ADN. Se porta además la utilizacion de dicha composicion para la transferencia in vitro, ex vivo y/o in vivo de ácidos nucleicos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR95/11411 | 1995-09-28 | ||
FR9511411A FR2739292B1 (fr) | 1995-09-28 | 1995-09-28 | Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations |
FR9511411 | 1995-09-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9801920A true MX9801920A (es) | 1998-08-30 |
MXPA98001920A MXPA98001920A (es) | 1998-11-12 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
ZA968109B (en) | 1997-04-21 |
FR2739292A1 (fr) | 1997-04-04 |
EP0854930A1 (fr) | 1998-07-29 |
FR2739292B1 (fr) | 1997-10-31 |
CZ94798A3 (cs) | 1998-07-15 |
US6153597A (en) | 2000-11-28 |
IL123849A0 (en) | 1998-10-30 |
WO1997012051A1 (fr) | 1997-04-03 |
NO981322D0 (no) | 1998-03-24 |
JPH11512704A (ja) | 1999-11-02 |
HUP9900317A3 (en) | 2001-10-29 |
SK40098A3 (en) | 1998-09-09 |
CA2231064A1 (fr) | 1997-04-03 |
BR9610719A (pt) | 1999-07-13 |
HUP9900317A2 (hu) | 1999-05-28 |
AU720697B2 (en) | 2000-06-08 |
NO981322L (no) | 1998-03-24 |
KR19990063814A (ko) | 1999-07-26 |
AU7136196A (en) | 1997-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA961255B (en) | Pharmaceutical composition containing nucleic acids and uses thereof | |
UA66417C2 (en) | Recombinant adenovirus affecting canines, pharmaceutical composition | |
DE69835201D1 (en) | Neoglycoproteine | |
CA2090700A1 (en) | Modified antibodies with controlled clearance time | |
NZ512792A (en) | Stable liquid interferon beta formulations | |
DE69535328D1 (de) | In-vitro wachstum von langerhans'schen inseln und ihre verwendungen | |
CY2396B1 (en) | Pharmaceutical composition of fenofibrate with high biological availability and method for preparingsame. | |
PT1053256E (pt) | Anticorpos para o receptor de morte 4 (dr4) e utilizações destes | |
MX9700270A (es) | Composicion que contiene acidos nucleicos, preparacion y utilizacion. | |
AU5743996A (en) | Compositions and methods for nucleic acid delivery to the lu ng | |
ATE177757T1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
HUP9800049A3 (en) | Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf | |
ZA983851B (en) | Substituted 3,3-diamino-2-propenenitriles their preparation and use | |
CA2231176A1 (en) | Long active composition for rectal administration | |
WO1997028812A3 (en) | Pharmaceutical compositions for biological treatment of infections by enterococcus faecium strains resistant to antibiotics and to vancomycin in particular (vre) | |
HUP9900317A3 (en) | Pharmaceutical composition useful for nucleic acid transfection, and use thereof | |
AU617036B2 (en) | Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom | |
WO1990007321A3 (en) | Lymphocyte receptor homing sequences and their uses | |
CA2242750A1 (en) | Antibodies with reduced net positive charge | |
ZA984970B (en) | Processes for preparation of Marek's disease virus using continuous mammalian cell lines. | |
MY103584A (en) | 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
HUP0200345A2 (hu) | Új nukleinsav-transzferáló ágensek, ezeket tartalmazó készítmények és alkalmazásuk | |
Peijun et al. | Research on Dynamic Creep and Long-term Strength of Sand | |
Sakalo et al. | Lymphoscintigraphy of patients with penis cancer.; Lyimfostsintigrafyiya u khvorikh na rak statevogo chlena. | |
UA9690A (uk) | Індуктор інтерферону першого типу в культурах клітин |